Matinas Biopharma Hl (MTNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,628 | -11,573 | -5,513 | -20,997 | -17,363 |
| Depreciation Amortization | 791 | 536 | 273 | 1,109 | 830 |
| Accounts payable and accrued liabilities | 217 | -13 | -102 | -321 | -282 |
| Other Working Capital | 2,462 | 2,277 | -119 | -4,789 | -2,503 |
| Other Operating Activity | 3,459 | 2,493 | 1,374 | 5,842 | 4,461 |
| Operating Cash Flow | $-10,699 | $-6,280 | $-4,087 | $-19,156 | $-14,857 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 10,500 | 9,400 | 3,000 | 5,769 | 5,769 |
| PPE Investments | -218 | -202 | N/A | -892 | -850 |
| Investing Cash Flow | $10,282 | $9,198 | $3,000 | $4,877 | $4,919 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -6 | -5 | -4 | -20 | -15 |
| Common Stock Issued | N/A | N/A | N/A | 99 | 99 |
| Financing Cash Flow | $-6 | $-5 | $-4 | $79 | $84 |
| Beginning Cash Position | 7,080 | 7,080 | 7,080 | 21,280 | 21,280 |
| End Cash Position | 6,657 | 9,993 | 5,989 | 7,080 | 11,426 |
| Net Cash Flow | $-423 | $2,913 | $-1,091 | $-14,200 | $-9,854 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,699 | -6,280 | -4,087 | -19,156 | -14,857 |
| Capital Expenditure | -218 | -202 | N/A | -892 | -850 |
| Free Cash Flow | -10,917 | -6,482 | -4,087 | -20,048 | -15,707 |